2Feigh VL, Rinkel GJ, Algra A, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev,2000: CD000277.
3Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodiphae on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipme trial. BMJ, 1989, 298:636 - 642.
4Kassell NF, Haley EC Jr, Apperson-Hansen C, et al. Randomized,double-blind, vehicle-controlled trial of thilazad mesyiate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg, 1996, 84:221 -228.
5Lanzmo G, Kassell NF, Dorsch NW, et al. Double-blind, randomized, vehicle-controlled study of high-dose tkilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study kl Europe, Australia, New Zealand, and South Africa. J Neurosure. 1999.90:1011 -1017.
6Haley EC Jr, Kassell NF, Apperson-Hansen C, et al. A randomized,double-blind, vehicle-controlled trial of tkilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg, 1997, 86:467 -474.
7Lanzmo G, Kassell NF. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate ha women with aneurysmal subarachnoid hemorrhage. Part Ⅱ. A cooperative study in North America. J Neurosurg, 1999, 90:1018 -1024.
8Asano T, Takakura K, Sano K, et al. Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits followhag aneurvsm-al subarachnoid hemorrhage: results of a multicenter, placebocontrolled double-blind trial. J Neurosurg, 1996, 84:792 -803.
9Saito I. Asano T, Sano K, et al. Neuroprotective effect of an antioxidant, ebselen, hi patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery, 1998, 42:269 - 278.
10Juvela S, Kaste M, Hilbom M. Platelet thromboxane release after subarachnoid hemorrhage and surgery. Stroke, 1990, 21 : 566 -571.
